Abstract: The present invention relates to novel tetracycline derivatives, to intermediates used in their preparation, to pharmaceutical compositions containing them and to their medicinal use.

Abstract: A curable epoxy resin composition comprising (A) an epoxy resin, (B) a thixotropic agent in an amount sufficient to induce thixotropic properties, and a hardener comprising (C) at least one polyethyleneimine and (D) at least one other amine having at least 2 amino hydrogen atoms, the combined amounts of (C) and (D) being sufficient to effect cure of the epoxy resin.

Abstract: Damaged thermoplastics can be outstandingly stabilized by the use of a mixture comprising a) 0.05 to 20% by weight, based on the plastic to be stabilized, of at least one polyfunctional epoxide, b) 0.01 to 2% by weight, based on the plastic to be stabilized, of at least one sterically hindered phenol.

Abstract: Compounds of the formula (I) ##STR1## in which the polydispersity Mw/Mn is 1; n is 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15; the radicals R.sub.1 are for example hydrogen or C.sub.1 -C.sub.8 alkyl; R.sub.2 is for example C.sub.2 -C.sub.12 alkylene; the radicals A are independently of one another --OR.sub.3, --N(R.sub.4)(R.sub.5) or a group of the formula ##STR2## R.sub.3, R.sub.4 and R.sub.5, which are identical or different, are for example hydrogen or C.sub.1 -C.sub.18 alkyl,or --N(R.sub.4)(R.sub.5) is additionally a group of the formula ##STR3## with Y being --O--, --CH.sub.2 --, --CH.sub.2 CH.sub.2 -- or >N--CH.sub.3 ; X is --O-- or >N--R.sub.6 ; R.sub.6 is for example hydrogen or C.sub.1 -C.sub.18 alkyl; R is preferably a group of the formula ##STR4## and the radicals B have independently of one another one of the definitions given for A; with the proviso that in the individual recurrent units of the formula (I), each of the radicals B, R, R.sub.1 and R.sub.

Abstract: A synergistic stabilizer mixture comprising a component a) and, for example, a component b), where component a) is at least one compound of the formula I ##STR1## in which R.sub.1 is C.sub.1 -C.sub.10 alkyl, C.sub.5 -C.sub.12 cycloalkyl, C.sub.1 -C.sub.4 alkyl-substituted C.sub.5 -C.sub.12 cycloalkyl, phenyl or C.sub.1 -C.sub.10 alkyl-substituted phenyl,R.sub.2 is C.sub.3 -C.sub.10 alkylene,R.sub.3 is hydrogen, C.sub.1 -C.sub.8 alkyl, O.sup..cndot., --CH.sub.2 CN, C.sub.3 -C.sub.6 alkenyl, C.sub.7 -C.sub.9 phenylalkyl, C.sub.7 -C.sub.9 phenylalkyl which is substituted on the phenyl radical by C.sub.1 -C.sub.4 alkyl; or C.sub.1 -C.sub.8 acyl, andn.sub.1 is a number from 1 to 50,and component b) is, for example, a compound of the formula ##STR2## in which n.sub.2 is a number from 2 to 20.

Abstract: A synergistic stabilizer mixture comprising a component a) and, for example, a component b), where component a) is at least one compound of the formula I ##STR1## in which R.sub.1 is hydrogen or methyl, R.sub.2 is a direct bond or C.sub.1 -C.sub.10 alkylene, and n.sub.1 is a number from 2 to 50; component b) is at least one compound of the formulae IIa and IIb ##STR2## in which n.sub.2 and n.sub.2 * are a number from 2 to 50.

Abstract: The present invention relates to new compounds which are useful as ultraviolet absorbing agents (UVAs) and as fluorescent whitening agents (FWAs), and to a method of improving the sun protection factor (SPF) of textile fiber material, especially cotton, polyamide and wool, treated with the new compounds and with certain known compounds.

Abstract: A process for resolving 1-azabicyclo[2.2.2]octan-3-amine, (2-diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] in which 1-azabicyclo[2.2.2]octan-3-amine, (2-diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] is reacted with 1R-(-)-10-camphorsulfonic acid in a solvent capable of dissolving both the foregoing reactants and selectively dissolving the camphorsulfonic acid salt of the corresponding (2R, 3R) enantiomer relative to the (2S, 3S) enantiomer.

Abstract: The pyrazoles and pyzazolopyrimidines of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective In the treatment of a wide range of diseases including stress-related illnesses.

Abstract: The disclosure describes pigment compositions containing a small particle size porous filler and a pigment, and their use for preparing effect coating compositions which produce thin film finishes exhibiting strong lightness and color flop with a pronounced three dimensional effect. The thin film finishes are particularly interesting as automotive finishes.

Abstract: Dye mixtures comprising at least one dye of the formula (1) ##STR1## together with at least one dye of the formula (2) or (3) ##STR2## in which the substituents are as defined in claim 1 are direct dyes for cellulosic fibre materials in particular. They are stable at high temperatures and are particularly suitable for the one-bath, single-stage dyeing of polyester/cotton blends with a disperse dye for the polyester fibres under the dyeing conditions for polyester fibres.

Abstract: Dye mixtures comprising at least one compound of the formula ##STR1## and at least one compound of the formula ##STR2## in which the variables are as defined in the claims,which are suitable as fibre-reactive dyes for dyeing widely varying fibre materials, are described.

Abstract: The present invention relates to a process for the continuous dyeing of cellulose fiber yarns with reactive dyes and to an apparatus for carrying out this process.The process essentially comprises steps of impregnating yarn which has been continuously unwound at high speed from one or several supports (1) and rewound onto one or several supports (3) with at least one fiber-reactive dye in aqueous solution and at least one alkaline reagent in aqueous solution, and fixing the dye.The invention can be applied especially in the technical field of dyeing cellulose fibers.

Abstract: Compounds of the formula The compounds are useful in the treatment of bacterial infections.

Abstract: Pigment powder mixtures, consisting of0.999-0.5 part of C.I. Pigment Yellow 184, and0.001-0.5 part of an organic pigment selected from the group consisting of C.I. Pigment Orange 13, C.I. Pigment Orange 34, C.I. Pigment Orange 36, C.I. Pigment Orange 73, C.I. Pigment Red 170, C.I. Pigment Red 254, C.I. Pigment Red 255 and C.I. Pigment Red 264,or of0.99-0.5 part of C.I. Pigment Yellow 184, and0.01-0.5 part of an organic pigment selected from the group consisting of C.I. Pigment Yellow 83, C.I. Pigment Yellow 110 and C.I. Pigment Yellow 139.These pigment powder mixtures are distinguished, in particular in paints, by very high chroma.

Abstract: A novel process for the preparation of compounds of formula I ##STR1## by aminolysis of a p-halophenyl alkyl ketone of formula II ##STR2## with a cyclic amine of formula III ##STR3## in water at a temperature of at least 130.degree. C., in which formulae X is a halogen atom and R.sub.1, R.sub.2 and R.sub.3 are as claimed in claim 1, as well as the novel compounds of formula I and their use for the preparation of photoinitiators for the photopolymerisation of ethylenically unsaturated compounds.

Abstract: Process for dichromatic or trichromatic dyeing or printing of natural or synthetic polyamide fibre material, which comprises using at least one blue-dyeing fibre-reactive anthraquinone dye of the formula ##STR1## in which R.sub.1 and R.sub.2 independently of one another are hydrogen or substituted or unsubstitutedC.sub.1 -C.sub.12 alkyl,X.sub.1 is halogen,B.sub.1 is an organic bridge member andV.sub.1 is an aliphatic or aromatic amine containing a fibre-reactive group,together with at least one fibre-reactive sulfo group containing yellow- or orange-dyeing dye ortogether with at least one fibre-reactive sulfo group containing red-dyeing dye. Level dyeings with good fastness properties are obtained.

Abstract: A liquid crystalline compound of formula ##STR1## wherein B and D are each independently of the other C.sub.6 -C.sub.24 alkyl, ##STR2## L is ##STR3## methyl or C.sub.10 -C.sub.18 alkyl, wherein R.sub.1 is C.sub.4 -C.sub.18 alkyl, with the proviso that when L is methyl, at least one of B and D is C.sub.6 -C.sub.24 alkyl;R2 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, halogen, cyano or nitro,R3, R4 and R5 are each independently of one another hydrogen, OR6, SR6, SeR6, --NHR6, --NR6R7, ##STR4## with the proviso that at least one of R3, R4 and R5 is not hydrogen, R6 is C.sub.7 -C.sub.37 alkyl, C.sub.7 -C.sub.37 alkylene or C.sub.5 -C.sub.18 alkyl which is interrupted by 1 to 6 hetero atoms selected from the group consisting of O, S and N,R7 is hydrogen or R9,R8 is hydrogen or C.sub.1 -C.sub.4 alkyl, andR9 is C.sub.1 -C.sub.12 alkyl, C.sub.2 -C.sub.12 alkylene or C.sub.3 -C.sub.12 alkyl which is interrupted by 1 to 6 hetero atoms selected from the group consisting of O, S and N.

Abstract: Compounds of the formula ##STR1## in which the variables are as defined in the claims, which are suitable as fibre-reactive dyes for dyeing widely varying fibre materials, are described.

Abstract: Compounds of the formula ##STR1## wherein R.sup.1 AND R.sup.2 are as defined, useful in the treatment of asthma, rheumatoid arthritis, osteoarthritis, bronchitis, chronic obstructive airways diseases, psoriasis, allergic rhinitis, atopic dermatitis, shock, and other inflammatory diseases and for blocking the leucotriene D4 receptor, pharmaceutical compositions containing such compounds and methods of blocking leucotriene D4 receptors using such compositions.